AbbVie Inc.
ABBV
$246.53
$2.731.12%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 16.99B | 15.00B | 16.62B | 15.78B | 15.42B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 16.99B | 15.00B | 16.62B | 15.78B | 15.42B |
| Cost of Revenue | 4.29B | 4.22B | 4.55B | 4.46B | 4.35B |
| Gross Profit | 12.70B | 10.78B | 12.07B | 11.32B | 11.08B |
| SG&A Expenses | 3.55B | 3.49B | 3.82B | 3.43B | 3.18B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | 0.00 | -- | -24.00M |
| Total Operating Expenses | 10.19B | 10.18B | 10.95B | 10.18B | 9.64B |
| Operating Income | 6.80B | 4.82B | 5.67B | 5.60B | 5.79B |
| Income Before Tax | 4.28B | 1.04B | 2.67B | 714.00M | 1.55B |
| Income Tax Expenses | 662.00M | 342.00M | 853.00M | 526.00M | 613.00M |
| Earnings from Continuing Operations | 3.62B | 697.00M | 1.82B | 188.00M | 941.00M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -3.00M | -2.00M | 1.00M | -2.00M | -3.00M |
| Net Income | 3.61B | 695.00M | 1.82B | 186.00M | 938.00M |
| EBIT | 6.80B | 4.82B | 5.67B | 5.60B | 5.79B |
| EBITDA | 8.69B | 6.76B | 7.66B | 7.66B | 7.84B |
| EPS Basic | 2.04 | 0.39 | 1.02 | 0.10 | 0.52 |
| Normalized Basic EPS | 2.14 | 1.48 | 1.81 | 1.81 | 1.83 |
| EPS Diluted | 2.03 | 0.39 | 1.02 | 0.10 | 0.52 |
| Normalized Diluted EPS | 2.14 | 1.47 | 1.81 | 1.80 | 1.83 |
| Average Basic Shares Outstanding | 1.77B | 1.77B | 1.77B | 1.77B | 1.77B |
| Average Diluted Shares Outstanding | 1.77B | 1.78B | 1.77B | 1.77B | 1.77B |
| Dividend Per Share | 1.73 | 1.73 | 1.73 | 1.64 | 1.64 |
| Payout Ratio | 84.97% | 444.03% | 160.30% | 1,565.05% | 310.23% |